Article Figures & Data
Figures
- FIGURE 1.
General scheme describing the optimization strategy.
- FIGURE 2.
Distribution of pediatric studies at site 1 (2018) (A) and site 2 (2017) (B). MIBI = methoxyisobutylisonitrile.
- FIGURE 3.
(A) Activities administered for 99mTc-DMSA renal cortical scans at baseline and NACG-recommended activities for same patients. Average relative difference compared with NACG-recommended values is reported for each age group. (B) Same data reported as function of weight.
- FIGURE 4.
Activities administered to pediatric patients for 99mTc-DMSA renal cortical scans after introduction of optimization intervention. (A) Comparison, as function of age, with NACG-recommended activities for same patients. Average relative difference compared with NACG-recommended values is reported for each age group. (B) Comparison, as function of weight, with activities that would have been administered at baseline and NACG-recommended values for same patients.
- FIGURE 5.
Baseline administered activity level for 3 example ages, simulated activity value corresponding to noise level of 23% and 25%, activity recommended by EANM, and same value increased by 50%.
- FIGURE 6.
(A and B) Activities administered to pediatric patients for 99mTc-DMSA renal cortical scans at baseline, after introduction of optimization intervention, and EANM-recommended activities for same patients as function of age (A) and weight (B). (C) Relative difference in administered activities at baseline and after introduction of optimization intervention compared with EANM-recommended values.
Tables
- TABLE 1
Administered Activities for 3 Example Ages for 99mTc-DMSA Projects at Sites 1 and 2 at Baseline and After Optimization: Comparison to Recommended Values for EANM Pediatric Dosage Card and NACG
Age (y) Weight (kg) EANM NACG Site 1 BL Site 1 Opt Site 2 BL Site 2 Opt 1 10 18.5 18.5 50 35 100 28 5 20 33 37 85 60 125 50 10 32 50 59 120 84 155 74 BL = baseline; Opt = after optimization.
Data are megabecquerels.
